Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Teveten Hct Patent Expiration

Teveten Hct is a drug owned by Abbvie Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 12, 2014. Details of Teveten Hct's patents and their expiration are given in the table below.

Filter patents by

Country : United States(US)
Drug Patent Number Drug Patent Title Drug Patent Expiry Status
These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5656650 Angiotensin II receptor blocking compositions
Aug, 2014

(10 years ago)

Expired

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

US patents provide insights into the exclusivity only within the United States, but Teveten Hct is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Teveten Hct's family patents as well as insights into ongoing legal events on those patents.

Teveten Hct's Family Patents


Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List


Generic Launch

Generic Release Date:

Teveten Hct's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 12, 2014 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Teveten Hct Generics:

There are no approved generic versions for Teveten Hct as of now.

Alternative Brands for Teveten Hct

Teveten Hct which is used for managing high blood pressure., has several other brand drugs in the same treatment category . Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.

Drug Owner Drug Name Treatment Area
Abbott
Hytrin Used for treating hypertension and symptomatic benign prostatic hyperplasia.
Abbvie
Teveten Used for managing high blood pressure.
Adhera
Prestalia Used for treating high blood pressure.
Allergan
Bystolic Used for treating high blood pressure.
Ani Pharms
Atacand Hct Used for treating high blood pressure.
Azurity
Edarbi Used for lowering blood pressure.
Epaned Used for managing heart failure and hypertension.
Edarbyclor Used for managing high blood pressure.
Boehringer Ingelheim
Twynsta Used for managing high blood pressure.
Micardis Used for the treatment of cardiovascular conditions such as myocardial infarction, hypertension, and stroke.
Micardis Hct Used for lowering high blood pressure.
Cosette
Azor Used for managing high blood pressure.
Benicar Used for lowering high blood pressure.
Tribenzor Used for lowering high blood pressure.
Benicar Hct Used for managing high blood pressure.
Noden Pharma
Tekturna Used for treating high blood pressure.
Tekturna Hct Used for lowering high blood pressure.
Novartis
Diovan Used for managing hypertension and reducing cardiovascular mortality in stable patients with left ventricular failure or dysfunction post-myocardial infarction.
Exforge Used for treating high blood pressure.
Tekamlo Used for treating high blood pressure.
Valturna Used for managing high blood pressure.
Amturnide Used for lowering high blood pressure (hypertension).
Diovan Hct Used for treating high blood pressure.
Exforge Hct Used for treating high blood pressure.
Upjohn
Inspra Used for treating hypertension, heart failure, and conditions related to hyperaldosteronism, often in combination with an ACE inhibitor.
Waylis Therap
Coreg Cr Used for managing congestive heart failure and hypertension to reduce mortality.





About Teveten Hct

Teveten Hct is a drug owned by Abbvie Inc. It is used for managing high blood pressure. Teveten Hct uses Eprosartan Mesylate; Hydrochlorothiazide as an active ingredient. Teveten Hct was launched by Abbvie in 2001.

Approval Date:

Teveten Hct was approved by FDA for market use on 01 November, 2001.

Active Ingredient:

Teveten Hct uses Eprosartan Mesylate; Hydrochlorothiazide as the active ingredient. Check out other Drugs and Companies using Eprosartan Mesylate; Hydrochlorothiazide ingredient

Treatment:

Teveten Hct is used for managing high blood pressure.

Dosage:

Teveten Hct is available in tablet form for oral use. Given below is detailed information on Dosage -

Strength Dosage Form Availability Application Pathway
600MG;12.5MG TABLET Discontinued ORAL
600MG;25MG TABLET Discontinued ORAL